Table 1 Demographics of included patients
Group | Patients analysed | Age (y) | BMI | Gender (M/F %) | ASA status (1/2) | Surgical time (m) | Reversal time (m) |
|---|---|---|---|---|---|---|---|
Shallow/saline | 12 | 54 (42–63) | 26 (23–30) | 50/50 | 4/8 | 162 (108–281) | |
Shallow/sugammadex | 10 | 51 (41–65) | 27 (24–28) | 27/73 | 3/6 | 168 (137–213) | |
Moderate/neostigmine | 11 | 56 (49–59) | 25 (21–28) | 40/60 | 2/9 | 178 (106–278) | 17 (11–27) |
Moderate/sugammadex | 13 | 54 (30–68) | 26 (24–28) | 46/54 | 3/10 | 134 (114–198) | 2 (2–2) |
Deep/sugammadex | 9 | 55 (41–63) | 24 (21–27) | 33/67 | 2/7 | 208 (177–234) | 2 (2–3) |